Corbus Pharmaceuticals Holdings (CRBP) Notes Payables (2013 - 2024)
Corbus Pharmaceuticals Holdings' Notes Payables came in at $77,000 for Q2 2024, up 50.5% from $51,157 a year earlier but down 59.4% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Notes Payables (2013 - 2024) Analysis & Trends
At the end of FY2023, Corbus Pharmaceuticals Holdings' Notes Payables was $301,000, down 14.8% from FY2022.
- Notes Payables carries a five-year compound annual growth rate of -5.3% (FY2018 to FY2023).
- Going back by year, Notes Payables was $353,323 in FY2022 (-54.0%), $767,938 in FY2021 (+8.1%), $710,158 in FY2020 (-5.6%) and $752,659 in FY2019 (+90.9%).
- The five-year range for quarterly Notes Payables is $51,157 (Q2 2023) to $767,938 (Q4 2021).
- Year-over-year, Notes Payables increased in 1 of the last six quarters, with an average decline of 22.1%.
- The fastest year-over-year change in Notes Payables over five years came in Q4 2019 (growth of 90.9%), and the weakest in Q4 2022 (a decline of 54.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 52.74 Mn | -463.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 189,818.00 |
| Dec 31, 2023 | 301,000.00 |
| Jun 30, 2023 | 51,157.00 |
| Mar 31, 2023 | 203,258.00 |
| Dec 31, 2022 | 353,323.00 |
| Jun 30, 2022 | 110,705.00 |
| Mar 31, 2022 | 440,815.00 |
| Dec 31, 2021 | 767,938.00 |
| Jun 30, 2021 | 102,693.00 |
| Mar 31, 2021 | 408,278.00 |
| Dec 31, 2020 | 710,158.00 |
| Jun 30, 2020 | 108,936.00 |
| Mar 31, 2020 | 432,905.00 |
| Dec 31, 2019 | 752,659.00 |
| Jun 30, 2019 | 99,333.00 |
| Mar 31, 2019 | 247,384.00 |
| Dec 31, 2018 | 394,305.00 |
| Jun 30, 2018 | 83,704.00 |
| Mar 31, 2018 | 208,648.00 |
API Access
Corbus Pharmaceuticals Holdings Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();